Earlier age-at-onset is reported for both groups, while differences in cognition and depression rates are common in the GBA mutation carriers with PD, and gait dysfunction and postural instability, as well as, a more mild disease progression may be more common in the LRRK2 mutation carriers than that seen in iPD6,9–12. The gene discussed is LRRK2; the disease is Parkinson disease.